Xilio Therapeutics, Inc. (XLO)
NASDAQ·Healthcare·Biotechnology
$7.99
-0.25%
Mkt Cap $28.36M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$98.00
Range $98.00 – $98.00
Implied Upside
+1126.5%
Consensus $98.00 vs current $7.99
NASDAQ·Healthcare·Biotechnology
$7.99
-0.25%
Mkt Cap $28.36M
No recent rating data.
Price Target (1 analysts)
$98.00
Range $98.00 – $98.00
+1126.5%
Consensus $98.00 vs current $7.99